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Are HIV-positive presumptive tuberculosis patients without  
tuberculosis getting the care they need in Zimbabwe?
R. A. Dlodlo,1 Z. E. Hwalima,2 S. Sithole,2 K. C. Takarinda,1,3 K. Tayler-Smith,4 A. D. Harries1,5
Among persons seeking care for symptoms sugges-tive of tuberculosis (TB) in sub-Saharan Africa, 
human immunodeficiency virus (HIV) prevalence 
rates of as high as 63% have been reported.1–3 These 
findings support the importance of offering provid-
er-initiated HIV testing and counselling (PITC) to pa-
tients with presumptive TB, an initiative that is now 
recommended in the international guidelines for col-
laborative TB-HIV activities; PITC was previously rec-
ommended only for patients diagnosed with TB.4
In high TB-HIV burden countries, among presump-
tive TB patients found to have TB, an increasing num-
ber undergo HIV testing. Of those found to be 
HIV-positive, a substantial proportion are started on 
antiretroviral therapy (ART),5 which is known to im-
prove survival and TB treatment outcomes.6 In con-
trast, little is known about what happens to presump-
tive TB patients who are found not to have TB but 
who are diagnosed as HIV-positive. This could be com-
pounded by the fact that internationally recom-
mended indicators for monitoring collaborative TB-
HIV activities focus primarily on HIV-positive patients 
with TB and not on HIV-positive patients without TB.7
Since the 1990s, Zimbabwe has experienced a dev-
astating HIV-associated TB epidemic.8 While great 
strides have been made in the diagnosis and treatment 
of HIV-positive TB patients, with 91% of patients 
knowing their HIV status and 77% of HIV-positive TB 
patients accessing ART in 2013,5 less attention has 
been paid to whether HIV-positive presumptive TB pa-
tients without TB benefit from ART. A study from Zim-
babwe that followed up this patient group suggested 
that they fare poorly, with limited ART access and a 
high 12-month mortality rate.9
The present study aimed to compare the HIV diag-
nostic and treatment cascade, including ART initia-
tion, in presumptive TB patients with and without TB 
in a primary health care facility in Bulawayo, Zimba-
bwe. The study objective was to determine annual 
numbers and proportions of presumptive TB patients 
who were HIV tested and found to be positive between 
2009 and 2013. Other objectives were to determine, 
among presumptive TB patients registered in 2013, 1) 
the number and proportion HIV tested and found to 
be HIV-positive, 2) the number and proportion newly 
diagnosed as HIV-positive without TB who were eligi-
ble for ART, and 3) the number and proportion newly 
diagnosed as HIV-positive who were started on ART 
and cotrimoxazole preventive therapy (CPT), based on 
their TB status.
METHODS
Study design
This was a retrospective cohort study using routine 
programme data.
Study setting
General
Zimbabwe, situated in southern Africa, is one of the 
countries hardest hit by the HIV epidemic, with an 
HIV prevalence of approximately 15% among persons 
aged 15–49 years.10 It also has a large TB epidemic, 
with 32 899 new and relapse TB cases reported in 
2013, equating to a notification rate of 233 per 
100 000 population.5
Management of presumptive TB patients and ART 
eligibility in Zimbabwe
In Zimbabwe, a presumptive TB patient is defined as a 
person presenting with a chronic cough of 2 weeks.11 
A register for presumptive TB patients was introduced 
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Setting: Emakhandeni Clinic provides decentralised and 
integrated tuberculosis (TB) and human immunodefi-
ciency virus (HIV) care in Bulawayo, Zimbabwe.
Objectives: To compare HIV care for presumptive TB pa-
tients with and without TB registered in 2013.
Design: Retrospective cohort study using routine pro-
gramme data.
Results: Of 422 registered presumptive TB patients, 26% 
were already known to be HIV-positive. Among the re-
maining 315 patients, 255 (81%) were tested for HIV, of 
whom 190 (75%) tested HIV-positive. Of these, 26% 
were diagnosed with TB and 71% without TB (3% had 
no TB result recorded). For the 134 patients without TB, 
antiretroviral treatment (ART) eligibility data were re-
corded for 42 (31%); 95% of these were ART eligible. Ini-
tiation of cotrimoxazole preventive therapy (CPT) and 
ART was recorded for respectively 88% and 90% of 
HIV-positive patients with TB compared with respectively 
40% and 38% of HIV-positive patients without TB (P  
0.001).
Conclusion: Presumptive TB patients without TB had a 
high HIV positivity rate and, for those with available data, 
most were ART eligible. Unlike HIV-positive patients diag-
nosed with TB, CPT and ART uptake for these patients 
was poor. A ‘test and treat’ approach and better service 
linkages could be life-saving for these patients, especially 
in southern Africa, where there are high burdens of HIV 
and TB.
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in 2007 to monitor TB detection. A year later, informa-
tion on HIV test results was also included.
The diagnosis of TB is based mainly on sputum 
smear microscopy of acid-fast bacilli (AFB) using the 
Ziehl-Neelsen method and, more recently, on rapid 
molecular testing using Xpert® MTB/RIF (Cepheid Inc, 
Sunnyvale, CA, USA). A patient is defined as having 
bacteriologically confirmed TB if 1) at least one sputum 
microscopy result is AFB-positive, or 2) an Xpert result 
is positive for Mycobacterium tuberculosis, or 3) M. tuber-
culosis grows on culture. Presumptive TB patients 
whose sputum results are negative and who do not 
have a positive response to a course of antibiotics are 
evaluated by a medical officer who may make a clinical 
diagnosis, often based on chest radiographic findings.
HIV testing and counselling are offered to persons 
with presumptive TB who have not previously tested 
HIV-positive, in accordance with national guidelines.12 
HIV test results usually become available during the 
first clinic visit and, if positive, the patient is started on 
CPT. World Health Organization (WHO) clinical stag-
ing for HIV infection, CD4 cell count measurement 
and other tests follow. These patients are supposed to 
be referred for pre-ART and ART care and recorded in 
the respective registers. Before December 2013, 
HIV-positive patients classified as WHO clinical stage 3 
or 4 and/or with a CD4 cell count 350 cells/mm3 were 
considered eligible for ART initiation in Zimbabwe.13
Study site
Bulawayo is the second largest city in Zimbabwe, with 
an estimated population of 653 000 in 2012.14 Since 
the mid-1990s, decentralised TB diagnostic and treat-
ment services have been provided through 19 primary 
health care clinics, one microscopy laboratory and one 
infectious diseases hospital. Since 2004, free-of-charge 
HIV treatment and care, including ART initiation and 
follow up, have gradually been decentralised and inte-
grated into the general health services provided by the 
clinics. The national TB and HIV care recording and re-
porting tools are used. One of the city’s health facili-
ties, Emakhandeni Clinic, which has a catchment pop-
ulation of 30 000, provides comprehensive curative 
and preventive services and manages on average 100 
out-patients daily. It has no in-patient facilities. The 
staff consist of one visiting medical doctor, 10 nurses 
and seven auxiliary staff. 
Study population
The study included all presumptive TB patients attend-
ing Emakhandeni Clinic between January 2009 and 
December 2013. HIV testing and test results were re-
ported for all patients, and a more detailed assessment 
was undertaken for patients registered between 1 Janu-
ary and 31 December 2013.
Data variables, collection and source of data
For all presumptive TB patients registered between 
2009 and 2013, information on HIV testing and results 
was collected. For those patients registered in 2013, ad-
ditional data variables included: name, age, sex and TB 
status and, for HIV-positive presumptive TB patients, 
assessment for ART eligibility with clinical staging or 
CD4 cell count and ART and CPT initiation. Data were 
sourced from the presumptive TB, TB, pre-ART and 
ART registers and clinic-based patient ART folders. Pa-
tients in the various registers were linked by name, age 
and sex. The study data were collected from 1 March 
to 30 April 2015 and double-entered using EpiData En-
try software (version 3.1, EpiData Association, Odense, 
Denmark).
Analysis and statistics
A descriptive analysis was performed using frequencies 
and proportions. Differences between groups were de-
termined using the χ2 test and the Wilcoxon rank sum 
test for continuous variables. Levels of significance 
were set at 5%. Data were analysed using EpiData 
Analysis software (version 2.2.182).
Ethics approval
Ethics approval for the study was obtained from the 
Health Services Department of the City of Bulawayo, 
Zimbabwe, and from the Ethics Advisory Group of the 
International Union Against Tuberculosis and Lung 
Disease, Paris, France. As the study was based on record 
review, informed patient consent was not required.
RESULTS
HIV testing and positivity rates among 
presumptive TB patients
Figure 1 shows the annual number of presumptive TB 
patients by HIV testing status and result from 2009 to 
2013. The number of presumptive TB patients increased 
from 386 in 2009 to 565 in 2011, after which it stayed 
relatively constant; it was 422 in 2013. The proportion 
of patients tested for HIV increased from 56% in 2009 
and plateaued from 2011 onwards, at 76–86%. Among 
patients tested for HIV, positivity rates decreased over 
consecutive years but remained high (77–88%).
Presumptive TB patients registered in 2013
Characteristics of newly diagnosed HIV-positive 
patients
Figure 2 shows the HIV and TB diagnostic cascade for 
presumptive TB patients registered in 2013. Of the 422 
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FIGURE 1 Number of presumptive TB patients by HIV 
testing status and result, Emakhandeni Clinic, Bulawayo, 
Zimbabwe, 2009–2013. TB = tuberculosis; HIV = human 
immunodeficiency virus.
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registered patients, 107 (26%) were already known to be HIV-posi-
tive, and of these, 30 (28%) were found to have TB and 103 (96%) 
had been started on ART (data not shown). Among the remaining 
315 patients without a known HIV positive status, 255 (81%) 
were tested for HIV, of whom 190 (75%) were found to be 
HIV-positive. Of these HIV-positive patients, 26% were diagnosed 
with TB (15 by bacteriological confirmation and 35 by clinical di-
agnosis) and 71% without TB; 3% had no recorded TB test result. 
No differences in sex or age distribution were found between 
newly diagnosed HIV-positive presumptive TB cases with and 
without TB (data not shown).
ART eligibility among newly diagnosed HIV-positive patients 
without TB
Among the 134 newly diagnosed HIV-positive patients found not 
to have TB, data on ART eligibility were only recorded in 42 (31%) 
cases, of whom 40 (95%) were ART eligible (Table). Age and sex 
distribution was similar for those with and without ART eligibility 
data.
CPT and ART initiation among newly diagnosed HIV-positive 
presumptive TB patients by TB status
Among 184 newly diagnosed HIV-positive patients with a known 
TB test result, CPT and ART initiation was recorded for respec-
tively 44 (88%) and 45 (90%) patients with TB vs. respectively 53 
(40%) and 51 (38%) patients without TB (P  0.001) (Figure 3).
DISCUSSION
This is the first study from Zimbabwe to report on how HIV-posi-
tive presumptive TB patients found not to have TB access HIV 
care at the primary health care level where decentralised and inte-
grated TB and HIV services have been provided since 2008. Our 
study findings showed that of approximately 500 patients with 
presumptive TB registered annually, approximately 80% were 
newly tested for HIV, and that among those tested, HIV positivity 
was high. An assessment of patients registered in 2013 revealed 
that one in four patients was already known to be HIV-positive 
and undergoing ART. For newly tested patients, three quarters 
were found to be HIV-infected, and 70% of these were found not 
to have TB. Almost all HIV-positive patients without TB for whom 
data were available were eligible for ART. Nonetheless, HIV-posi-
tive non-TB patients were in general far less likely to be initiated 
on CPT or ART compared with HIV-positive TB patients.
The strengths of this study are that it involved a large number 
of presumptive TB patients and that it was conducted in a routine 
setting, thus likely reflecting the operational realities on the 
ground. In addition, the study adhered to the Strengthening the 
FIGURE 2 TB and HIV diagnosis among registered presumptive TB 
patients, Emakhandeni Clinic, Bulawayo, Zimbabwe, 2013. *Previ-
ously tested HIV-positive status defined as a patient with a positive 
HIV result from at least 3 months earlier. TB = tuberculosis; HIV = hu-
man immunodeficiency virus.
TABLE Assessment of ART eligibility among newly diagnosed 
HIV-positive presumptive TB patients without TB, Emakhandeni 
Clinic, Bulawayo, Zimbabwe, 2013
Data on ART eligibility recorded n (%)
Total 134
No* 92 (69)
Yes 42 (31)
 Eligible for ART 40 (95)
 WHO stage 3 or 4 23
 WHO stage 1 or 2 & CD4 350 cells/mm3 17
 Not eligible for ART 2 (5)
* Includes any patient with 1) no WHO clinical stage or CD4 count recorded, or 2) 
WHO stage 1 or 2 recorded but no CD4 count recorded, or 3) no WHO clinical 
stage recorded and CD4 count 350 cells/mm3 recorded.
ART = antiretroviral treatment; HIV = human immunodeficiency virus; TB = tubercu-
losis; WHO = World Health Organization.
FIGURE 3 Number and proportion of newly diagnosed HIV-positive 
presumptive TB patients recorded as having started CPT and ART, by 
TB status, Emakhandeni Clinic, Bulawayo, Zimbabwe, 2013 (n = 
184).* *Includes only patients with a recorded TB test result (6 pa-
tients without a result). TB = tuberculosis; HIV = human immunodefi-
ciency virus; CPT = cotrimoxazole preventive treatment; ART = an-
tiretroviral treatment.
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Reporting of OBservational studies in Epidemiology (STROBE) 
guidelines.15
Limitations included the use of routine register data, which 
were incomplete in certain areas and may have been inaccurate. 
We also assumed that the large numbers of newly diagnosed 
HIV-positive presumptive patients without TB and not recorded 
as having started ART or CPT were not initiated on these inter-
ventions. We do not know this for certain, however; it is possible 
that the patients received ART at the clinic without documenta-
tion or were initiated elsewhere without the information being 
communicated to Emakhandeni Clinic. Finally, it is possible that 
clinically diagnosed TB patients may have been misdiagnosed as 
having TB and, conversely, that in severely immunosuppressed 
patients, clinical TB may have been missed in view of the fact 
that up to one quarter of such patients with culture-positive M. 
tuberculosis disease can be sputum smear-negative and have a nor-
mal chest radiograph.16
Previous studies reporting on the diagnosis and management 
of presumptive TB patients have found HIV testing uptake to 
range between 59% and 95%,17–22 which is comparable to our 
findings. In terms of ART enrolment, a study carried out in Ha-
rare, Zimbabwe, in the mid-2000s, a time when public health sec-
tor ART was largely unavailable, reported that only 15% of 
HIV-positive presumptive TB patients without TB were started on 
ART.9 We have demonstrated a better ART initiation rate among 
this patient group, although it is still much lower than among 
HIV-positive TB patients.
This study has several important programmatic implications. 
First, while the uptake of HIV testing among patients with pre-
sumptive TB was over 80%, attempts should be made to increase 
this to as close to 100% as possible, especially as the HIV positivity 
yield is high. This would not only be of benefit at the individual 
level, it would also assist Zimbabwe’s contribution towards the 
global goal of the joint United Nations Programme on HIV/AIDS 
(UNAIDS) to achieve its new 90–90–90 treatment targets for end-
ing the AIDS epidemic.23 These targets specify that by 2020, 90% of 
individuals living with HIV will be diagnosed and know their HIV 
status, 90% of people with HIV infection will receive sustained 
ART and 90% of those on ART will be virally suppressed. Knowl-
edge of HIV status for all patients is the gateway to this cascade.
Second, although data on ART eligibility for HIV-positive pa-
tients without TB were infrequent, most patients with available 
data were eligible. This suggests that this particular group of pa-
tients, similar to those with TB, could benefit from a ‘test and 
treat’ approach. Previous studies have already shown that 
HIV-positive presumptive TB patients without TB have high 
12-month mortality,9 and as such, offering them ART regardless 
of CD4 cell count should improve survival and potentially reduce 
the risk of TB. Until then, the assessment of ART eligibility needs 
to improve, including all patients having a baseline CD4 cell 
count measured and recorded.
Third, national TB programmes need to invest in newer tech-
nology to improve TB diagnosis in HIV-positive patients. Sputum 
smear microscopy followed by chest radiography in those with 
negative sputum smears is currently the mainstay for TB diagno-
sis. This approach is time consuming, costly for patients who 
need to make multiple journeys to the clinic and diagnostically 
insensitive.24,25 The Xpert assay, which is more sensitive and en-
ables a rapid TB diagnosis, needs to be scaled up.26
Fourth, more attention should be paid to follow-up and the 
monitoring of patients without TB. These patients enter the health 
system through the TB services, and it appears that once a diagno-
sis of TB has been excluded, their follow-up is weak. This is likely 
due to a lack of clear guidelines and monitoring of uptake of ser-
vices. The situation must change: clear procedures are required to 
guide staff, and collaboration should be strengthened between 
personnel in TB and HIV services through mentorship and super-
vision to ensure effective referral of these patients for HIV care.
Fifth, and related to the point above, is the need for better re-
cording and reporting of what happens to patients with presump-
tive TB, and especially those found to be HIV-positive. Registers 
for presumptive TB patients require additional columns explicitly 
for recording whether a newly diagnosed HIV-positive patient has 
been started on CPT and ART. Similarly, newly diagnosed HIV-in-
fected patients, with or without TB, need to be recorded in the 
ART registers. The WHO should have a section in the annual 
global TB report on HIV testing and care for presumptive TB 
patients.
In conclusion, this study showed that in a primary health care 
setting in Zimbabwe, a high proportion of presumptive TB pa-
tients found not to have TB were HIV-positive and that of those 
with available data, most were eligible for ART. Unlike HIV-posi-
tive patients with TB, however, enrolment into HIV care for these 
non-TB patients was poor. A ‘test and treat’ approach and better 
TB-HIV service linkages could be life-saving for these patients, es-
pecially in southern Africa with high burdens of HIV and TB.
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Contexte  :  Le centre de santé Emakhandeni, qui offre une prise en 
charge de la tuberculose (TB) et du virus de l’immunodéficience 
humaine (VIH) décentralisée et intégrée à Bulawayo, Zimbabwe.
Objectifs  :  Comparer la prise en charge du VIH pour les patients 
présumés tuberculeux, avec et sans TB, enregistrés en 2013.
Schéma  :  Etude rétrospective de cohorte basée sur les données de 
routine du programme.
Résultats  :  Sur 422 patients présumés tuberculeux enregistrés, 26% 
étaient connus comme VIH positifs. Parmi les 315 patients restants, 255 
(81%) ont eu un test VIH, dont 190 (75%) se sont avérés positifs. Parmi 
eux, 26% ont eu un diagnostic de TB et 71% n’ont pas été confirmés 
tuberculeux (les 3% restants n’ont eu aucun résultat de TB enregistré). 
Pour les 134 patients sans TB, les données d’éligibilité au traitement 
antirétroviral (ART) ont été notées chez 42 (31%) patients et 95% ont 
été éligibles à l’ART. La mise en œuvre du traitement préventif par 
cotrimoxazole (CPT) et l’ART a été notée pour respectivement 88% et 
90% des patients VIH positifs avec TB, comparés à respectivement 40% 
et 38% des patients VIH positifs sans TB (P  0,001).
Conclusion  :  Les patients présumés TB mais non confirmés avaient 
un taux élevé de positivité au VIH et pour ceux dont les données 
étaient disponibles, la majorité était éligible à l’ART. Par contre, pour 
les patients VIH positifs sans une TB confirmée, le taux de mise en 
œuvre du traitement préventif par CPT et de l’ART a été médiocre. 
Une approche « tester et traiter » et de meilleurs liens entre les 
services pourraient sauver la vie de ces patients, surtout en Afrique 
australe où les taux de VIH et de TB sont très élevés.
Marco de referencia: El consultorio Emakhandeni ofrece atención 
descentralizada e integrada de la tuberculosis (TB) y la infección por 
el virus de la inmunodeficiencia humana (VIH) en Bulawayo, 
Zimbabue.
Objetivo: Comparar el servicio de atención de la infección por el VIH 
en los pacientes registrados con presunción clínica de TB cuyo 
diagnóstico se confirmó o se infirmó en el 2013.
Método: Fue este un estudio retrospectivo de cohortes a partir de 
los datos corrientes del programa.
Resultados: De los 422 pacientes registrados con presunción clínica 
de TB, el 26% contaba ya con una serología positiva frente al VIH. De 
los 315 pacientes restantes, en 255 se practicó la serología (81%) y 
190 obtuvieron un resultado positivo (75%). De estos pacientes se 
confirmó el diagnóstico de TB en el 26% y se infirmó en el 71% (en 
el 3% no se registró ningún resultado sobre la TB). De los 134 
pacientes sin TB, se consignaron datos sobre los criterios de inclusión 
en el tratamiento antirretrovírico (ART) en 42 casos (31%) y el 95% 
cumplía con estos criterios. En los pacientes seropositivos frente al 
VIH con TB se registró el comienzo del tratamiento preventivo con 
cotrimoxazol (CPT) en el 88% y del ART en el 90%, en comparación 
con el 40% y el 38%, respectivamente, en los pacientes seropositivos 
sin diagnóstico de TB (P  0,001).
Conclusión: Los pacientes con presunción clínica de TB en quienes 
se infirmó el diagnóstico presentaron una alta tasa de seropositividad 
frente al VIH y en los pacientes con datos registrados, la mayoría 
cumplía con los criterios de iniciación del ART. En estos pacientes la 
aceptación del CPT y el ART fue baja, a diferencia de los pacientes 
seropositivos con diagnóstico de TB. Una estrategia de ‘prueba 
diagnóstica y tratamiento’ y una mayor vinculación de los servicios 
podrían contribuir a salvar vidas en este grupo de pacientes, sobre 
todo en el sur de África, donde existen altas tasas de morbilidad por 
la infección por el VIH y la TB.
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